Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Cigna and Primary Partners announce new collaborative care initiative

Cigna Corporation, a health insurance service company, and Primary Partners LLC, a physician owned and managed accountable care organization, have launched a collaborative care initiative to improve patient access to health care and enhance care coordination.

Published By MarketLine
20 Nov 2014
NewsWire
NewsWire

Asterias Biotherapeutics Q3 net loss down

Asterias Biotherapeutics, Inc., a biotechnology company, has reported that net loss for the third quarter ended September 30, 2014 was $1.68 million, or $0.05 loss per share, compared to a net loss of $2.67 million, or $51.62 loss per share, for the same quarter ended September 30, 2013.

Published By MarketLine
20 Nov 2014
NewsWire
NewsWire

Halozyme Therapeutics Q3 net loss up

Halozyme Therapeutics, Inc., a biopharmaceutical company, has reported that net loss for the third quarter ended September 30, 2014 was $20.28 million, or $0.16 loss per share, compared to a net loss of $19.29 million, or $0.17 loss per share, for the same quarter ended September 30, 2013.

Published By MarketLine
20 Nov 2014
NewsWire
NewsWire

Rhoen Klinikum reports lower Q3 income, provides guidance for 2015

Rhoen Klinikum AG, a provider of health care services, has reported that consolidated income attributable to the shareholders for the third quarter ended September 30, 2014 was E12.31 million, or E0.09 per share, compared to E17.09 million, or E0.12 per share, for the same quarter ended September 30, 2013. For 2015, the company expects revenues to be in the range of E1.06 billion to E1.12 billion.

Published By MarketLine
20 Nov 2014
NewsWire
NewsWire

OP Financial to build new hospital network in Finland under Pohjola brand

OP Financial Group has announced that it will build a new hospital network in Finland under the Pohjola brand.

Published By MarketLine
20 Nov 2014
NewsWire
NewsWire

Biotest receives marketing authorization for human albumin solution in China

Biotest AG, a supplier of biological medications, has received the marketing authorization for Albiomin 20%, or solution of human albumin, from the Chinese FDA.

Published By MarketLine
20 Nov 2014
NewsWire
NewsWire

Nuvo Research reports net income for Q3

Nuvo Research Inc., a specialty pharmaceutical company, has reported that net income for the third quarter ended September 30, 2014 was C$49.78 million, or C$4.80 per diluted share, compared to a net loss of C$2.95 million, or C$0.34 loss per diluted share, for the same quarter ended September 30, 2013.

Published By MarketLine
20 Nov 2014
NewsWire
NewsWire

Osiris Therapeutics reports net income for Q3

Osiris Therapeutics, Inc., a biotechnology company, has reported that net income for the third quarter ended September 30, 2014 was $645,000, or $0.02 per share, compared to a net loss of $1.68 million, or $0.05 loss per share, for the same quarter ended September 30, 2013.

Published By MarketLine
20 Nov 2014
NewsWire
NewsWire

Fibrocell Science Q3 net loss down

Fibrocell Science, Inc., an autologous cell therapy company, has reported that net loss for the third quarter ended September 30, 2014 was $6.01 million, or $0.17 loss per diluted share, compared to a net loss of $6.6 million, or $0.31 loss per diluted share, for the same quarter ended September 30, 2013.

Published By MarketLine
20 Nov 2014
NewsWire
NewsWire

PDL BioPharma Q3 net income up

PDL BioPharma, Inc., a biotechnology company, has reported that net income for the third quarter ended September 30, 2014 was $102.23 million, or $0.61 per diluted share, compared to $56.22 million, or $0.36 per diluted share, for the same quarter ended September 30, 2013.

Published By MarketLine
20 Nov 2014

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.